Celularity Stock (NASDAQ: CELU) stock price, news, charts, stock research, profile.
Open | $2.80 |
Close | $3.13 |
Volume / Avg. | 25.08K / 34.42K |
Day Range | 2.74 - 3.13 |
52 Wk Range | 1.59 - 7.97 |
Market Cap | $68.18M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 5.88% |
Days to Cover | 35.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Celularity (NASDAQ:CELU) through any online brokerage.
Other companies in Celularity’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR), Eagle Pharmaceuticals (NASDAQ:EGRX) and Barinthus Biotherapeutics (NASDAQ:BRNS).
There is no analysis for Celularity.
Celularity has a consensus price target of $4.90.
The stock price for Celularity (NASDAQ: CELU) is $3.13 last updated June 28, 2024 at 5:28 PM EDT.
There are no upcoming dividends for Celularity.
Celularity’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Celularity.
Celularity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.